Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of the study is to compare efficacy and safety of palliative chemotherapy EOX and mDCF regimens in the first-line treatment of patients with advanced HER2-negative gastric and gastroesophageal junction (GEJ) adenocarcinoma
Epistemonikos ID: 9292ba957f31c53fe84491bad0ced21945280fe9
First added on: May 12, 2024